全文获取类型
收费全文 | 463篇 |
免费 | 38篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 19篇 |
妇产科学 | 12篇 |
基础医学 | 81篇 |
口腔科学 | 1篇 |
临床医学 | 44篇 |
内科学 | 78篇 |
皮肤病学 | 15篇 |
神经病学 | 53篇 |
特种医学 | 10篇 |
外科学 | 31篇 |
综合类 | 5篇 |
预防医学 | 50篇 |
眼科学 | 6篇 |
药学 | 52篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2024年 | 1篇 |
2023年 | 9篇 |
2022年 | 13篇 |
2021年 | 28篇 |
2020年 | 23篇 |
2019年 | 22篇 |
2018年 | 30篇 |
2017年 | 16篇 |
2016年 | 17篇 |
2015年 | 21篇 |
2014年 | 10篇 |
2013年 | 30篇 |
2012年 | 39篇 |
2011年 | 55篇 |
2010年 | 18篇 |
2009年 | 11篇 |
2008年 | 26篇 |
2007年 | 27篇 |
2006年 | 21篇 |
2005年 | 18篇 |
2004年 | 19篇 |
2003年 | 19篇 |
2002年 | 11篇 |
2001年 | 2篇 |
2000年 | 4篇 |
1999年 | 1篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1994年 | 1篇 |
1993年 | 2篇 |
1990年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
排序方式: 共有503条查询结果,搜索用时 15 毫秒
21.
Melisa Dirchwolf Gonzalo Gomez Perdiguero Ingrid Mc Grech Sebastian Marciano 《World journal of hepatology》2023,15(3):377-385
There is abundant evidence that bacterial infections are severe complications in patients with cirrhosis,being the most frequent trigger of acute-on-chronic liver failure and causing death in one of every four patients during hospitalization.For these reasons,early diagnosis and effective treatment of infections are mandatory to improve patient outcomes.However,treating physicians are challenged in daily practice since diagnosing bacterial infections is not always straightforward.This situation ... 相似文献
22.
23.
24.
25.
The proportion of hepatitis B virus(HBV) previously exposed patients who receive immunosuppressive treatment is usually very small. However, if these individuals are exposed to potent immunosuppressive compounds, the risk of HBV reactivation(HBVr) increases with the presence of hepatitis B surface antigen(HBsAg) in the serum. Chronic HBsAg carriers have a higher risk than those who have a total IgG anticore as the only marker of resolved/occult HBV disease. The loss of immune control in these patients may results in the reactivation of HBV replication within hepatocytes. Upon reconstitution of the immune system, infected hepatocytes are once again targeted and damaged by immune surveillance in an effort to clear the virus. There are different virological scenarios, and a wide spectrum of associated drugs with specific and stratified risk for the development of HBVr. Some of this agents can trigger a severe degree of hepatocellular damage, including hepatitis, acute liver failure, and even death despite employment of effective antiviral therapies. Currently, HBVr incidence seems to be increasing around the world; a fact mainly related to the incessant appearance of more powerful immunosuppressive drugs launched to the market. Moreover, there is no consensus on the length of prophylactic treatment before the patients are treated with immunosuppressive therapy, and for how long this therapy should be extended once treatment is completed. Therefore, this review article will focus on when to treat, when to monitor, what patients should receive HBV therapy, and what drugs should be selected for each scenario. Lastly, we will update the definition, risk factors, screening, and treatment recommendations based on both current and different HBV management guidelines. 相似文献
26.
Nika Finelt M.D. Rishi R. Lulla M.D. M.S. Hector Melin‐Aldana M.D. Jennifer Shuley Ruth M.D. Frank Y. Lin M.D. Jack M. Su M.D. Crystal Y. Pourciau M.D. M.P.H. Raegan D. Hunt M.D. Ph.D. Brandi M. Kenner‐Bell M.D. 《Pediatric dermatology》2017,34(3):337-341
Vemurafenib is increasingly being used to treat nonmelanoma tumors that are positive for the BRAF V600E mutation. We report three children who presented with panniculitis induced by vemurafenib while undergoing treatment for central nervous system tumors and review the literature. 相似文献
27.
28.
29.
Pulmonary arterial hypertension (PAH) is a severely disabling disorder characterized by sustained elevations of pulmonary vascular resistance, ultimately leading to right-heart failure and death. Intravenous epoprostenol has been widely used in patients with PAH, leading to long-term clinical benefits and improved survival. Epoprostenol has to be delivered through a permanently implanted intravenous catheter, with the potential of life-threatening complications. Thus, treprostinil, a stable prostacyclin analog suitable for subcutaneous administration, has been developed. Treprostinil is chemically stable at room temperature, has a long half-life (2-4 hours), and has similar pharmacologic properties with comparable hemodynamic effects as epoprostenol.A large, double-blind, placebo-controlled, multicenter, 12-week study confirmed the efficacy of subcutaneous treprostinil, by improving exercise capacity, Borg Dypnea Score (BDS), New York Heart Association (NYHA) class, and clinical signs and symptoms in patients with PAH. Subsequently, multiple observational studies reported the long-term effects of subcutaneous treprostinil. The long-term survival of patients treated with subcutaneous treprostinil was similar to that reported with intravenous epoprostenol. Pain at the infusion site has been a major drawback of subcutaneous treprostinil, hampering dose titration and leading to an 8-10% discontinuation rate. In addition, studies have examined the efficacy of intravenous treprostinil in the treatment of patients with PAH. An open-label study demonstrated that intravenous treprostinil improved exercise capacity, BDS, NYHA functional class, and hemodynamics at week 12 compared with baseline. Transitioning from intravenous epoprostenol to intravenous treprostinil is safe and effective. The dose of intravenous treprostinil has to be adjusted to approximately twice the dose of intravenous epoprostenol. Most patients have reported less severe adverse effects with intravenous treprostinil compared with intravenous epoprostenol. The assessment of the long-term efficacy and safety of continuous intravenous treprostinil requires further studies. 相似文献
30.
A great deal of interest has developed regarding the impact of cognitive deficits on the everyday functioning of people with schizophrenia. This study examined the relationships between cognitive functioning and the performance of a specific independent living skill (grocery shopping) in a sample of 73 individuals with schizophrenia or schizoaffective disorder. Cognitive variables included tests of verbal memory, executive functioning, verbal fluency, sustained attention and visual motor skill. Functional outcome was measured with the Test of Grocery Shopping Skills, which is an ecologically based performance measure that requires participants to shop for 10 items within an actual grocery store. Accuracy on the shopping task was significantly associated with fewer perseverative responses on the Wisconsin Card Sorting Test, better verbal memory and faster processing speed. Shopping efficiency (i.e. less redundancy) was associated with better performance on several cognitive tasks, including verbal memory, verbal fluency, sustained attention and executive functioning. Results of this study extend previous research by examining the relation between cognition and the actual performance of daily living skills under natural circumstances. 相似文献